Ryan N Hansen

Summary

Publications

  1. ncbi request reprint Health care costs among renal cancer patients using pazopanib and sunitinib
    Ryan N Hansen
    University of Washington, Box 357630, Seattle, WA 98195
    J Manag Care Spec Pharm 21:37-44, 44a-d. 2015
  2. doi request reprint Bioequivalent antiepileptic drug switching and the risk of seizure-related events
    Ryan N Hansen
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, United States
    Epilepsy Res 106:237-43. 2013
  3. pmc Electronic prescribing at the point of care: a time-motion study in the primary care setting
    Emily Beth Devine
    Biomedical and Health Informatics, School of Medicine, University of Washington, Seattle, WA
    Health Serv Res 45:152-71. 2010
  4. doi request reprint Association between antiepileptic drug switching and epilepsy-related events
    Ryan N Hansen
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, 1959 NE Pacific Avenue, Seattle, WA 98195, USA
    Epilepsy Behav 15:481-5. 2009
  5. pmc The impact of computerized provider order entry on medication errors in a multispecialty group practice
    Emily Beth Devine
    Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle, Washington 98195 7630, USA
    J Am Med Inform Assoc 17:78-84. 2010
  6. doi request reprint Estimating the cost-effectiveness of onabotulinumtoxinA for neurogenic detrusor overactivity in the United States
    Josh J Carlson
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA
    Clin Ther 35:414-24. 2013
  7. pmc Sedative Hypnotic Medication Use and the Risk of Motor Vehicle Crash
    Ryan N Hansen
    Ryan N Hansen, Denise M Boudreau, and Sean D Sullivan are with the Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle Denise M Boudreau is also with and David C Grossman is with the Group Health Research Institute, Seattle Beth E Ebel is with the Harborview Injury Prevention and Research Center, Seattle, and the Departments of Pediatrics and Epidemiology, and Health Services, University of Washington David C Grossman and Sean D Sullivan are also with the Department of Health Services, University of Washington
    Am J Public Health 105:e64-9. 2015
  8. doi request reprint Economic costs of nonmedical use of prescription opioids
    Ryan N Hansen
    Department of Pharmacy, Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, Washington, USA
    Clin J Pain 27:194-202. 2011
  9. doi request reprint Comparative effectiveness research in the United States: a progress report
    Sean D Sullivan
    Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, 1959 NE Pacific Ave, Seattle, WA 98195 7630, USA
    J Med Econ 16:295-7. 2013

Detail Information

Publications9

  1. ncbi request reprint Health care costs among renal cancer patients using pazopanib and sunitinib
    Ryan N Hansen
    University of Washington, Box 357630, Seattle, WA 98195
    J Manag Care Spec Pharm 21:37-44, 44a-d. 2015
    ....
  2. doi request reprint Bioequivalent antiepileptic drug switching and the risk of seizure-related events
    Ryan N Hansen
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, United States
    Epilepsy Res 106:237-43. 2013
    ..We investigated the association between A-rated switching of each class of currently available AED and emergent treatment for a seizure-related event...
  3. pmc Electronic prescribing at the point of care: a time-motion study in the primary care setting
    Emily Beth Devine
    Biomedical and Health Informatics, School of Medicine, University of Washington, Seattle, WA
    Health Serv Res 45:152-71. 2010
    ..Two primary aims were to compare prescribing time between (1) handwritten and electronic (e-) prescriptions and (2) e-prescriptions using differing hardware configurations...
  4. doi request reprint Association between antiepileptic drug switching and epilepsy-related events
    Ryan N Hansen
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, 1959 NE Pacific Avenue, Seattle, WA 98195, USA
    Epilepsy Behav 15:481-5. 2009
    ..These findings suggest that care should be taken when considering a switch between A-rated AEDs in patients with epilepsy...
  5. pmc The impact of computerized provider order entry on medication errors in a multispecialty group practice
    Emily Beth Devine
    Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle, Washington 98195 7630, USA
    J Am Med Inform Assoc 17:78-84. 2010
    ..The objective was to evaluate the effect of a basic, ambulatory CPOE system on medication errors and associated ADEs...
  6. doi request reprint Estimating the cost-effectiveness of onabotulinumtoxinA for neurogenic detrusor overactivity in the United States
    Josh J Carlson
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA
    Clin Ther 35:414-24. 2013
    ..However, the economic impact of onabotulinumtoxinA treatment for UI due to NDO in the United States remains unknown...
  7. pmc Sedative Hypnotic Medication Use and the Risk of Motor Vehicle Crash
    Ryan N Hansen
    Ryan N Hansen, Denise M Boudreau, and Sean D Sullivan are with the Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle Denise M Boudreau is also with and David C Grossman is with the Group Health Research Institute, Seattle Beth E Ebel is with the Harborview Injury Prevention and Research Center, Seattle, and the Departments of Pediatrics and Epidemiology, and Health Services, University of Washington David C Grossman and Sean D Sullivan are also with the Department of Health Services, University of Washington
    Am J Public Health 105:e64-9. 2015
    ..We sought to estimate the association between sedative hypnotic use and motor vehicle crash risk...
  8. doi request reprint Economic costs of nonmedical use of prescription opioids
    Ryan N Hansen
    Department of Pharmacy, Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, Washington, USA
    Clin J Pain 27:194-202. 2011
    ....
  9. doi request reprint Comparative effectiveness research in the United States: a progress report
    Sean D Sullivan
    Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, 1959 NE Pacific Ave, Seattle, WA 98195 7630, USA
    J Med Econ 16:295-7. 2013
    ..Expectations for CER are high and public and private investments are sizeable. This paper discussions the evolution of CER in the US and gives a brief report on its progress and challenges...